A Full Line Of Topical Biomedics Products At Discount Prices Only At The House Of Nutrition
About Topical Biomedics
In the 1980s, Topical BioMedics’ founders first recognized a significant void in the available options for effective and safe treatments for pain. Although we note advances made by the conventional and traditional health communities in many other areas today, pain management remains a debilitating challenge for millions of people.
As professionals at our nation’s hospitals strive to help the increasing number of sufferers, a new hope is emerging, a new respect evolving between conventional and traditional therapies for peripheral neuropathic and rheumatic pain.
Topical BioMedics’ research-based biopharmaceutical solutions are at the core of our work. We believe there is a much deeper dynamic evolving — providing a bridging mechanism between regulated natural medicines and all of primary care. Topricin®, our non-prescription medicine, lends itself as a synergistic tool for those who respect and desire safe and effective pain relief and healing.
As the National Institutes of Health invests millions to support platforms for research into complementary and conventional medicine, Topical BioMedics is helping bring together the best of these. Our primary work and mission is to drive an integrated evolving model for medicine--one where safe and effective treatments are widely available, and where no one has to live in pain. We invite you to join us in this important evolution.
Lou Paradise, President and CEO
Lou founded Topical BioMedics, following 25 years dedicated interest in the application of herbal and homeopathic medicines and therapies, and nutritional supplements to stimulate health and healing. Mr. Paradise’s enthusiasm, insight, and perseverance during a ten-year research and development phase led to the company’s breakthrough product, Topricin®.
Mr. Paradise frequently serves as an expert speaker on the use of natural medicines on nationally syndicated radio, and conducts pain management seminars for audiences throughout the northeast. Lou has participated in addressing compliance issues related to natural medicines with the U.S. Food and Drug Administration, and regularly speaks to clinical audiences on the use of the company’s proprietary technologies in the treatment of acute and chronic pain, and trauma injury as a compliment to primary care. Formerly, Lou worked in the brokerage and aerospace industries.